NEOACTT
DEAD

Serial Number

88786904

Owner

NEOGENOMICS LABORATORIES, INC.

Attorney

Anessa O. Kramer

Filing Date

Feb 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NEOACTT Trademark

Serial Number: 88786904

NEOACTT is a trademark filed by NEOGENOMICS LABORATORIES, INC. on February 6, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NEOGENOMICS LABORATORIES, INC. (84 trademarks)

12701 COMMONWEALTH DRIVE, SUITE 9
FORT MYERS, FL 33913

Entity Type: 03

Trademark Details

Filing Date

February 6, 2020

Registration Date

Not Registered

Published for Opposition

March 30, 2021

Goods & Services

Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific purposes; molecular sequencing for scientific purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells all being for scientific purposes; clinical study and testing of cells for scientific or research purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; nondownloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for research purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research and scientific purposes, providing medical research information and interactive scientific research information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of non-downloadable cloud based software for providing information to others to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online nondownloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; software as a service (SAAS) services featuring software for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis; providing cloud-based non-downloadable computer software providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes

Providing online, non-downloadable reports for others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions

Downloadable webinars in the fields of health, health related topics, cancer, cancer pathology, pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable software for medical testing and analysis of medical test results; downloadable software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; downloadable computer software and related downloadable databases all for use in nucleic acid and protein assay analysis and for quality control, clinical decision support, validation, interpretation, reporting, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to genomic analysis and molecular analysis

Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; medical testing for diagnostic purposes for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; medical testing services for diagnostic or treatment purposes provided by oncology reference laboratories

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 27, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 27, 2022 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 17, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jun 16, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 16, 2021 AITU
SOU EXTENSION 1 FILED
Jun 9, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 9, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 9, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 9, 2021 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 25, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 30, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2020 CRFA
ASSIGNED TO LIE
Nov 16, 2020 ALIE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 14, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 14, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 14, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 14, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 14, 2020 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2020 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 26, 2020 GPRN
PRIORITY ACTION E-MAILED
Apr 26, 2020 GPRA
PRIORITY ACTION WRITTEN
Apr 26, 2020 CPRA
ASSIGNED TO EXAMINER
Apr 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2020 NWOS
NEW APPLICATION ENTERED
Feb 10, 2020 NWAP